NM_001379500.1:c.1834-23C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001379500.1(COL18A1):​c.1834-23C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0717 in 1,611,454 control chromosomes in the GnomAD database, including 5,666 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.11 ( 1331 hom., cov: 33)
Exomes 𝑓: 0.068 ( 4335 hom. )

Consequence

COL18A1
NM_001379500.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.20

Publications

7 publications found
Variant links:
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL18A1 Gene-Disease associations (from GenCC):
  • Knobloch syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Knobloch syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
  • hereditary glaucoma, primary closed-angle
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 1 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 21-45487424-C-A is Benign according to our data. Variant chr21-45487424-C-A is described in ClinVar as Benign. ClinVar VariationId is 261894.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL18A1NM_001379500.1 linkc.1834-23C>A intron_variant Intron 16 of 41 ENST00000651438.1 NP_001366429.1
COL18A1NM_130444.3 linkc.3079-23C>A intron_variant Intron 15 of 40 NP_569711.2
COL18A1NM_030582.4 linkc.2374-23C>A intron_variant Intron 15 of 40 NP_085059.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL18A1ENST00000651438.1 linkc.1834-23C>A intron_variant Intron 16 of 41 NM_001379500.1 ENSP00000498485.1
COL18A1ENST00000355480.10 linkc.2374-23C>A intron_variant Intron 15 of 40 1 ENSP00000347665.5
COL18A1ENST00000359759.8 linkc.3079-23C>A intron_variant Intron 15 of 40 5 ENSP00000352798.4

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16339
AN:
152124
Hom.:
1330
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.225
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0778
Gnomad ASJ
AF:
0.0516
Gnomad EAS
AF:
0.0998
Gnomad SAS
AF:
0.106
Gnomad FIN
AF:
0.0160
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0617
Gnomad OTH
AF:
0.0942
GnomAD2 exomes
AF:
0.0730
AC:
18099
AN:
247794
AF XY:
0.0719
show subpopulations
Gnomad AFR exome
AF:
0.228
Gnomad AMR exome
AF:
0.0503
Gnomad ASJ exome
AF:
0.0480
Gnomad EAS exome
AF:
0.0959
Gnomad FIN exome
AF:
0.0199
Gnomad NFE exome
AF:
0.0607
Gnomad OTH exome
AF:
0.0669
GnomAD4 exome
AF:
0.0679
AC:
99141
AN:
1459212
Hom.:
4335
Cov.:
33
AF XY:
0.0682
AC XY:
49529
AN XY:
725924
show subpopulations
African (AFR)
AF:
0.235
AC:
7878
AN:
33460
American (AMR)
AF:
0.0549
AC:
2456
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0477
AC:
1247
AN:
26130
East Asian (EAS)
AF:
0.139
AC:
5512
AN:
39692
South Asian (SAS)
AF:
0.0945
AC:
8150
AN:
86228
European-Finnish (FIN)
AF:
0.0202
AC:
1045
AN:
51810
Middle Eastern (MID)
AF:
0.0825
AC:
442
AN:
5360
European-Non Finnish (NFE)
AF:
0.0609
AC:
67659
AN:
1111502
Other (OTH)
AF:
0.0788
AC:
4752
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4651
9302
13953
18604
23255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2704
5408
8112
10816
13520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16351
AN:
152242
Hom.:
1331
Cov.:
33
AF XY:
0.104
AC XY:
7739
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.225
AC:
9355
AN:
41526
American (AMR)
AF:
0.0775
AC:
1186
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0516
AC:
179
AN:
3472
East Asian (EAS)
AF:
0.0999
AC:
515
AN:
5156
South Asian (SAS)
AF:
0.105
AC:
508
AN:
4818
European-Finnish (FIN)
AF:
0.0160
AC:
170
AN:
10630
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0617
AC:
4197
AN:
68008
Other (OTH)
AF:
0.0932
AC:
197
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
704
1409
2113
2818
3522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0329
Hom.:
28
Bravo
AF:
0.117
Asia WGS
AF:
0.110
AC:
382
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.063
DANN
Benign
0.62
PhyloP100
-3.2
BranchPoint Hunter
1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73370824; hg19: chr21-46907338; COSMIC: COSV107421612; COSMIC: COSV107421612; API